Identification of Immunodominant Epitopes of Dengue Virus 2 Envelope and NS1 Proteins: Evaluating the Diagnostic Potential of a Synthetic Peptide

Overview

Journal Mol Diagn Ther

Specialties Molecular Biology
Pathology
Pharmacology

Date 2024 Jul 9

PMID 38980575

Authors

Sushmita Singha

Neena Nath

Vaishali Sarma

Kangkana Barman

Gurumayum Chourajit Sharma

Lahari Saikia

Shashi Baruah

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Dengue is a major infectious disease with potential for outbreaks and epidemics. A specific and sensitive diagnosis is a prerequisite for clinical management of the disease. We designed our study to identify epitopes on the Dengue virus (DENV) envelope (E) and non-structural protein 1 (NS1) with potential for diagnosis.

Methods: Serology and immunoinformatic approaches were employed. We collected DENV-positive, DENV-negative and Japanese encephalitis virus-positive samples from collaborating hospitals in 2019 and 2022-2023. Seropositive peptides in 15-18 mer peptide arrays of E and NS1 proteins of DENV2 were determined by an indirect enzyme-linked immunosorbent assay. B-cell linear and conformational epitopes were predicted using BepiPred2.0 and ElliPro, respectively. A consensus recombinant peptide was designed, synthesised and evaluated for its diagnostic potential using patient sera.

Results: Eight peptides of E protein and six peptides of NS1 protein were identified to be the most frequently recognised by Dengue-positive patients. These peptide sequences were compared with B-cell epitope regions and found to be overlapped with predicted B-cell linear and conformational epitopes. EP11 and NSP15 showed a 100% amino acid sequence overlap with B-cell epitopes. EP1 and NSP15 had 14 whereas EP28, EP31, EP60 16, NSP12 and NSP32 had more than 15 interacting interface residues with a neutralising antibody, suggesting a strength of interaction. Interestingly, potential epitopes identified were localised on the surface of proteins as visualised by PyMOL. Validation with a recombined synthetic peptide yielded 92.3% sensitivity and 91.42% specificity.

Conclusions: Immunodominant regions identified by serology and computationally predicted epitopes overlapped, thereby showing the robustness of the methodology and the peptide designed for diagnosis.

References

Bhatt S, Gething P, Brady O, Messina J, Farlow A, Moyes C . The global distribution and burden of dengue. Nature. 2013; 496(7446):504-7. PMC: 3651993. DOI: 10.1038/nature12060. View

Perera R, Kuhn R . Structural proteomics of dengue virus. Curr Opin Microbiol. 2008; 11(4):369-77. PMC: 2581888. DOI: 10.1016/j.mib.2008.06.004. View

Rai P, Kille S, Kotian A, Kumar B, Deekshit V, Ramakrishna M . Molecular investigation of the dengue outbreak in Karnataka, South India, reveals co-circulation of all four dengue virus serotypes. Infect Genet Evol. 2021; 92:104880. DOI: 10.1016/j.meegid.2021.104880. View

Chetry S, Khan S, Dutta P, Apum B, Medhi P, Saikia D . Dengue virus serotypes and genotypic characterization from northeast India. J Med Virol. 2019; 91(6):918-927. DOI: 10.1002/jmv.25418. View

Zaidi M, Cedillo-Barron L, Gonzalez Y Almeida M, Garcia-Cordero J, Campos F, Namorado-Tonix K . Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population. Acta Trop. 2019; 201:105201. DOI: 10.1016/j.actatropica.2019.105201. View

Masyeni S, Santoso M, Widyaningsih P, Asmara D, Nainu F, Harapan H . Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis. 2020; 102:152-154. PMC: 7585717. DOI: 10.1016/j.ijid.2020.10.043. View

Dwivedi V, Tripathi I, Chandra Tripathi R, Bharadwaj S, Mishra S . Genomics, proteomics and evolution of dengue virus. Brief Funct Genomics. 2017; 16(4):217-227. DOI: 10.1093/bfgp/elw040. View

Guzman M, Hermida L, Bernardo L, Ramirez R, Guillen G . Domain III of the envelope protein as a dengue vaccine target. Expert Rev Vaccines. 2010; 9(2):137-47. DOI: 10.1586/erv.09.139. View

Fan J, Liu Y, Yuan Z . Critical role of Dengue Virus NS1 protein in viral replication. Virol Sin. 2014; 29(3):162-9. PMC: 8206285. DOI: 10.1007/s12250-014-3459-1. View

10.

Hahn Y, Galler R, Hunkapiller T, Dalrymple J, Strauss J, Strauss E . Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses. Virology. 1988; 162(1):167-80. DOI: 10.1016/0042-6822(88)90406-0. View

11.

Putnak J, Charles P, Padmanabhan R, Irie K, Hoke C, Burke D . Functional and antigenic domains of the dengue-2 virus nonstructural glycoprotein NS-1. Virology. 1988; 163(1):93-103. DOI: 10.1016/0042-6822(88)90236-x. View

12.

Irie K, Mohan P, Sasaguri Y, Putnak R, Padmanabhan R . Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain). Gene. 1989; 75(2):197-211. DOI: 10.1016/0378-1119(89)90266-7. View

13.

Jespersen M, Peters B, Nielsen M, Marcatili P . BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 2017; 45(W1):W24-W29. PMC: 5570230. DOI: 10.1093/nar/gkx346. View

14.

Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O . Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596(7873):583-589. PMC: 8371605. DOI: 10.1038/s41586-021-03819-2. View

15.

Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, Duquerroy S, Vaney M, Kikuti C . Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature. 2015; 520(7545):109-13. DOI: 10.1038/nature14130. View

16.

Li L, Chen S, Miao Z, Liu Y, Liu X, Xiao Z . AbRSA: A robust tool for antibody numbering. Protein Sci. 2019; 28(8):1524-1531. PMC: 6635766. DOI: 10.1002/pro.3633. View

17.

Kozakov D, Hall D, Xia B, Porter K, Padhorny D, Yueh C . The ClusPro web server for protein-protein docking. Nat Protoc. 2017; 12(2):255-278. PMC: 5540229. DOI: 10.1038/nprot.2016.169. View

18.

Laskowski R, Jablonska J, Pravda L, Varekova R, Thornton J . PDBsum: Structural summaries of PDB entries. Protein Sci. 2017; 27(1):129-134. PMC: 5734310. DOI: 10.1002/pro.3289. View

19.

Phan I, Subramanian S, Kim D, Murphy M, Pettie D, Carter L . In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19. Sci Rep. 2021; 11(1):4290. PMC: 7900118. DOI: 10.1038/s41598-021-83730-y. View

20.

Aquino V, Fumagalli M, Silva A, de Moura Negrini B, Rojas A, Guillen Y . Linear epitope mapping in the E and NS1 proteins of dengue and Zika viruses: Prospection of peptides for vaccines and diagnostics. PLoS One. 2023; 18(10):e0292451. PMC: 10547212. DOI: 10.1371/journal.pone.0292451. View